As we sort through the results of the recent election, one thing that should be noted is what didn’t happen. The Biden-Harris Administration, despite intense pressure from its progressive allies, never finalized the pending march in guidelines. The draft guidelines, which issued late last year, were an attempt to misuse the landmark Bayh-Dole Act so the government could micro-manage the price of products based on federally-funded inventions. Critics of Bayh-Dole have tried for 20 years to turn the law, designed to decentralize technology management from Washington into the hands of those who make inventions in our public research institutions and companies, on its head so Washington could regulate prices.
Recent Posts
- Other Barks & Bites for Friday, August 1: Senate Commerce Approves Advanced Manufacturing and Space Bills; Ninth Circuit Affirms Narrow Application of Jack Daniel’s; and EU Commission Confirms Withdrawal of AI Directive and SEP Regulation
- SEP ESP: Deciphering the United States’ Views on Irreparable Harm
- Republican Senators Ask Trump Admin to Fill Vacant IP Post, Use Tariff Negotiations to Deliver on Drug Pricing Goals
- CAFC Faults Western Texas for Excluding On-Sale Bar Evidence, Urgers Proper Daubert Analysis on Remand
- Federal Circuit Transfers Case to Second Circuit for Lack of Jurisdiction to Review Decision Stemming from Arbitration